HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | SHIMOKAWA, Paulo Tadashi | |
dc.contributor.author | TARGA, Lilia Spaleta | |
dc.contributor.author | YAMAMOTO, Lidia | |
dc.contributor.author | RODRIGUES, Jonatas Cristian | |
dc.contributor.author | KANUNFRE, Kelly Aparecida | |
dc.contributor.author | OKAY, Thelma Suely | |
dc.date.accessioned | 2016-10-17T16:40:21Z | |
dc.date.available | 2016-10-17T16:40:21Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Host and parasite genotypes are among the factors associated with congenital toxoplasmosis pathogenesis. As HLA class II molecules play a key role in the immune system regulation, the aim of this study was to investigate whether HLA-DQA1/B1 alleles are associated with susceptibility or protection to congenital toxoplasmosis. One hundred and twenty-two fetuses with and 103 without toxoplasmosis were studied. The two study groups were comparable according to a number of socio-demographic and genetic variables. HLA alleles were typed by PCR-SSP. In the HLA-DQA1 region, the allele frequencies showed that *01:03 and *03:02 alleles could confer susceptibility ( OR= 3.06, p = 0.0002 and OR=9.60, p= 0.0001, respectively) as they were more frequent among infected fetuses. Regarding the HLA-DQB1 region, the *05: 04 allele could confer susceptibility ( OR = 6.95, p < 0.0001). Of the 122 infected fetuses, 10 presented susceptibility haplotypes contrasting with only one in the non-infected group. This difference was not statistically significant after correction for multiple comparison ( OR = 9.37, p=0.011). In the casuistic, there were two severely damaged fetuses with high parasite loads determined in amniotic fluid samples and HLA-DQA1 susceptibility alleles. In the present study, a discriminatory potential of HLA-DQA1/B1 alleles to identify susceptibility to congenital toxoplasmosis and the most severe cases has been shown. | |
dc.description.index | MEDLINE | |
dc.description.sponsorship | Sao Paulo Research Foundation - FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2010/15022-1] | |
dc.identifier.citation | VIRULENCE, v.7, n.4, p.456-464, 2016 | |
dc.identifier.doi | 10.1080/21505594.2016.1150401 | |
dc.identifier.eissn | 2150-5608 | |
dc.identifier.issn | 2150-5594 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/16267 | |
dc.language.iso | eng | |
dc.publisher | TAYLOR & FRANCIS INC | |
dc.relation.ispartof | Virulence | |
dc.rights | restrictedAccess | |
dc.rights.holder | Copyright TAYLOR & FRANCIS INC | |
dc.subject | Congenital toxoplasmosis | |
dc.subject | Genetic polymorphism | |
dc.subject | Genetic susceptibility | |
dc.subject | HLA alleles | |
dc.subject | polymerase chain reaction | |
dc.subject.other | polymerase-chain-reaction | |
dc.subject.other | sequence-specific primers | |
dc.subject.other | amniotic-fluid samples | |
dc.subject.other | gondii infection | |
dc.subject.other | follow-up | |
dc.subject.other | maternal reinfection | |
dc.subject.other | molecular diagnosis | |
dc.subject.other | gestational-age | |
dc.subject.other | human-disease | |
dc.subject.other | hla system | |
dc.subject.wos | Immunology | |
dc.subject.wos | Infectious Diseases | |
dc.subject.wos | Microbiology | |
dc.title | HLA-DQA1/B1 alleles as putative susceptibility markers in congenital toxoplasmosis | |
dc.type | article | |
dc.type.category | original article | |
dc.type.version | publishedVersion | |
dspace.entity.type | Publication | |
hcfmusp.author.external | SHIMOKAWA, Paulo Tadashi:Univ Sao Paulo, Inst Trop Med, Lab Seroepidemiol & Immunobiol, Sao Paulo, Brazil | |
hcfmusp.author.external | TARGA, Lilia Spaleta:Univ Sao Paulo, Inst Trop Med, Lab Seroepidemiol & Immunobiol, Sao Paulo, Brazil | |
hcfmusp.citation.scopus | 13 | |
hcfmusp.contributor.author-fmusphc | LIDIA YAMAMOTO | |
hcfmusp.contributor.author-fmusphc | JONATAS CRISTIAN RODRIGUES | |
hcfmusp.contributor.author-fmusphc | KELLY APARECIDA KANUNFRE | |
hcfmusp.contributor.author-fmusphc | THELMA SUELY OKAY | |
hcfmusp.description.beginpage | 456 | |
hcfmusp.description.endpage | 464 | |
hcfmusp.description.issue | 4 | |
hcfmusp.description.volume | 7 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.pubmed | 26856406 | |
hcfmusp.origem.scopus | 2-s2.0-84962091885 | |
hcfmusp.origem.wos | WOS:000380006900012 | |
hcfmusp.publisher.city | PHILADELPHIA | |
hcfmusp.publisher.country | USA | |
hcfmusp.relation.reference | Bessieres MH, 2009, MEM I OSWALDO CRUZ, V104, P389, DOI 10.1590/S0074-02762009000200038 | |
hcfmusp.relation.reference | Bidgoli S, 2011, J FR OPHTALMOL, V34, DOI 10.1016/j.jfo.2011.01.015 | |
hcfmusp.relation.reference | Costa JM, 2000, J CLIN MICROBIOL, V38, P2929 | |
hcfmusp.relation.reference | de Sorrentino AH, 2005, CLIN IMMUNOL, V115, P133, DOI 10.1016/j.clin.2005.01.003 | |
hcfmusp.relation.reference | Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765 | |
hcfmusp.relation.reference | Gavinet MF, 1997, J CLIN MICROBIOL, V35, P1276 | |
hcfmusp.relation.reference | Hill Dolores E., 2005, Animal Health Research Reviews, V6, P41, DOI 10.1079/AHR2005100 | |
hcfmusp.relation.reference | HOWE DK, 1995, J INFECT DIS, V172, P1561 | |
hcfmusp.relation.reference | Jaisson-Hot I, 2001, PRESSE MED, V30, P1001 | |
hcfmusp.relation.reference | Klein J, 2000, NEW ENGL J MED, V343, P782 | |
hcfmusp.relation.reference | Klein J, 2000, NEW ENGL J MED, V343, P702 | |
hcfmusp.relation.reference | Kodjikian L, 2004, PEDIATR INFECT DIS J, V23, P272, DOI 10.1097/01.inf.0000115949.12206.69 | |
hcfmusp.relation.reference | Kotb M, 2002, NAT MED, V8, P1398, DOI 10.1038/nm800 | |
hcfmusp.relation.reference | Ladas ID, 1999, OPHTHALMOLOGICA, V213, P320, DOI 10.1159/000027446 | |
hcfmusp.relation.reference | Lago EG, 2014, J PEDIAT-BRAZIL, V90, P363, DOI 10.1016/j.jped.2013.12.006 | |
hcfmusp.relation.reference | Mack DG, 1999, INT J PARASITOL, V29, P1351, DOI 10.1016/S0020-7519(99)00152-6 | |
hcfmusp.relation.reference | MEENKEN C, 1995, BRIT J OPHTHALMOL, V79, P494, DOI 10.1136/bjo.79.5.494 | |
hcfmusp.relation.reference | Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149 | |
hcfmusp.relation.reference | Morelle C, 2012, J CLIN MICROBIOL, V50, P3977, DOI 10.1128/JCM.01959-12 | |
hcfmusp.relation.reference | Mullighan CG, 1997, TISSUE ANTIGENS, V50, P688, DOI 10.1111/j.1399-0039.1997.tb02936.x | |
hcfmusp.relation.reference | Okay TS, 2009, CLINICS, V64, P171, DOI 10.1590/S1807-59322009000300004 | |
hcfmusp.relation.reference | OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x | |
hcfmusp.relation.reference | Pereira Ana Paula Esteves, 2013, BMC Res Notes, V6, P60, DOI 10.1186/1756-0500-6-60 | |
hcfmusp.relation.reference | Prusa AR, 2015, CLIN MICROBIOL INFEC, V21 | |
hcfmusp.relation.reference | Robert-Gangneux F, 2014, J INFECTION, V68, pS125, DOI 10.1016/j.jinf.2013.09.023 | |
hcfmusp.relation.reference | Romand S, 2004, AM J OBSTET GYNECOL, V190, P797, DOI 10.1016/j.ajog.2003.09.039 | |
hcfmusp.relation.reference | Sensini A, 2006, CLIN MICROBIOL INFEC, V12, P504, DOI 10.1111/j.1469-0691.2006.01444.x | |
hcfmusp.relation.reference | Silveira C, 2003, AM J OPHTHALMOL, V136, P370, DOI 10.1016/S0002-9394(03)00191-0 | |
hcfmusp.relation.reference | Sterkers Y, 2012, J CLIN MICROBIOL, V50, P3944, DOI 10.1128/JCM.00918-12 | |
hcfmusp.relation.reference | Tan TG, 2010, VACCINE, V28, P3977, DOI 10.1016/j.vaccine.2010.03.028 | |
hcfmusp.relation.reference | Teixeira LE, 2013, REV SOC BRAS MED TRO, V46, P584, DOI 10.1590/0037-8682-0095-2013 | |
hcfmusp.relation.reference | Thorsby E, 2009, TISSUE ANTIGENS, V74, P101, DOI 10.1111/j.1399-0039.2009.01291.x | |
hcfmusp.relation.reference | Trowsdale J, 2013, ANNU REV GENOM HUM G, V14, P301, DOI 10.1146/annurev-genom-091212-153455 | |
hcfmusp.relation.reference | Valdes V, 2011, ARCH PEDIATRIE, V18, P761, DOI 10.1016/j.arcped.2011.04.011 | |
hcfmusp.relation.reference | Villena I, 1998, SCAND J INFECT DIS, V30, P295 | |
hcfmusp.relation.reference | Wallon M, 2001, EUR J PEDIATR, V160, P534, DOI 10.1007/s004310100805 | |
hcfmusp.relation.reference | Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09 | |
hcfmusp.scopus.lastupdate | 2024-05-17 | |
relation.isAuthorOfPublication | a38bf500-fc7d-4398-ba8a-3c207001ac97 | |
relation.isAuthorOfPublication | 05e28bf3-92ba-47c4-8b98-5dcc216c76bf | |
relation.isAuthorOfPublication | 62e60a57-e9d1-4354-b9a9-bbdd6da549d0 | |
relation.isAuthorOfPublication | 6cda0b34-04dd-4679-8fb3-faa904acb401 | |
relation.isAuthorOfPublication.latestForDiscovery | a38bf500-fc7d-4398-ba8a-3c207001ac97 |
Arquivos
Pacote Original
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- art_SHIMOKAWA_HLADQA1B1_alleles_as_putative_susceptibility_markers_in_congenital_2016.PDF
- Tamanho:
- 999.67 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- publishedVersion (English)